Quirnsalud: Beta-blockers offer no benefit after a myocardial infarction, either in the acute or chronic phase, according to an analysis of the REBOOT trial led by the CNIC and with the participation of the IIS-FJD

Media coverage

• Title	Quirnsalud: Beta-blockers offer no benefit after a myocardial infarction, either in the acute or chronic phase, according to an analysis of the REBOOT trial led by the CNIC and with the participation of the IIS-FJD
  Media name/outlet	Contify Life Science News
  Country/Territory	India
  Date	6/02/26
  Persons	Valentin Fuster